Vical (VICL) +2.9% premarket after announcing that researchers at a Japan university have...

|About: Vical Incorporated (VICL)|By:, SA News Editor

Vical (VICL) +2.9% premarket after announcing that researchers at a Japan university have developed a DNA vaccine candidate using its Vaxfectin adjuvant with the potential to prevent transmission of malaria. (PR)